PD-1 binds PD-L1,PD-L2

Stable Identifier
R-HSA-9936162
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Programmed cell death protein 1 (PD-1, also known as PDCD1) binds to its ligands, PD-L1 (B7-H1, also known as CD274) and PD-L2 (B7-DC, also known as PDCD1LG2 or CD273), to exert its inhibitory effects on T cell activation and immune response. PD-1 displays different affinities for these ligands, with the PD-1:PD-L2 interaction exhibiting a 2- to 6-fold higher affinity compared to the PD-1:PD-L1 interaction, along with distinct association and dissociation kinetics. This binding primarily occurs at the immune synapse, where PD-1 engagement with its ligands leads to the recruitment of phosphatases SHP-1 (PTPN6) and SHP-2 (PTPN11). These phosphatases dephosphorylate key signaling molecules in the T cell receptor (TCR) pathway, resulting in reduced T cell proliferation, cytokine production, and overall immune response. The interaction of PD-1 with its ligands is crucial for maintaining immune tolerance and preventing autoimmunity, as well as contributing to immune evasion in cancer (Youngnak et al. 2003, Pentcheva-Hoang et al. 2007).
Literature References
PubMed ID Title Journal Year
12893276 Differential binding properties of B7-H1 and B7-DC to programmed death-1

Youngnak, P, Kozono, Y, Kozono, H, Iwai, H, Otsuki, N, Jin, H, Omura, K, Yagita, H, Pardoll, DM, Chen, L, Azuma, M

Biochem Biophys Res Commun 2003
Participants
Participates
This event is regulated
Orthologous Events
Authored
Reviewed
Created
Cite Us!